Lately, glutamine has been found to enhance the growth, spread, and drug resistance of cancer cells, while also fostering an immunosuppressive microenvironment that aids tumor development
On July 23 and 24, the FDA's Pharmacy Compounding Advisory Committee (PCAC) is meeting to consider whether certain peptides, including BPC-157, should be added to the 503A Bulks List, which is a list of drug substances that the FDA has approved for compounding
This is especially important for those who may have difficulty absorbing nutrients due to digestive issues, certain medical conditions, or simply because of age-related changes
Ensure they come with certificates of analysis (COAs) confirming their purity
Key Takeaways Tirzepatide slows gastric emptying by 4050%, reducing oral glutathione bioavailability from 2030% to 1218% during the 2448 hour peak effect window